ANTICUERPOS CONJUGADOS CD7.
Mexico·Clase II·III. Agentes de
diagnóstico·BECKMAN COULTER DE
MÉXICO, S.A. DE C.V.·Registered July 03, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ANTICUERPOS CD7 (CLONA 8H8.1) - MARCA BECKMAN.
- Trade Name (English)
- ANTICUERPOS CD7 (CLONA 8H8.1) - MARCA BECKMAN.
- Analysis ID
- 1884R2024 SSA
- Registration Date
- July 03, 2024
- Name (Spanish)
- BECKMAN COULTER DE MÉXICO, S.A. DE C.V.
- Name (English)
- BECKMAN COULTER DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for ANTICUERPOS CONJUGADOS CD7. (ANTICUERPOS CONJUGADOS CD7.) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1884R2024 SSA and manufactured by BECKMAN COULTER DE MÉXICO, S.A. DE C.V.. The device was registered on July 03, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.